Viewing Study NCT05917561


Ignite Creation Date: 2025-12-24 @ 12:54 PM
Ignite Modification Date: 2026-01-27 @ 4:41 AM
Study NCT ID: NCT05917561
Status: RECRUITING
Last Update Posted: 2023-12-22
First Post: 2023-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
Sponsor: University Hospital, Bordeaux
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Vitiligo View
Keywords:

Keywords

Keyword Brief Keyword Text View
None anifrolumab View
None vitiligo View
None phototherapy View
None randomized View